Relapse of Wegener's granulomatosis. Concerning a case after 20 years of remission

Joint Bone Spine

Volumn 68, Issue 3, 2001, Pages 262-266

  Foltz, Violaine ^a   Koeger, Anne Claude ^a   De Sauverzac, Catherine ^a   De Person, Jean François ^a   Bourgeois, Pierre ^a   Fautrel, Bruno ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Prevention; Relapse; Therapy; Wegener

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADULT; ARTHRALGIA; ARTICLE; ASPERGILLOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DYSPNEA; FEMALE; HEMOPTYSIS; HUMAN; PNEUMOCYSTIS CARINII; RELAPSE; REMISSION; RHINITIS; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0035006750     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(01)00268-8     Document Type: Article

References (31)

1. Walton E.W. Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis. Br Med J. 2:1958;265-270.
2. Blatt I.M., Lawrence M. Otologic manifestations of fatal granulomatosis of respiratory tract. Arch Otolaryngol. 73:1961;639-639.
3. Aldo M.A., Benson M.D., Comerford F.R., Cohen A.S. Treatment of Wegener's granulomatosis with immunosuppressive agents. Arch Intern M. 126:1970;298-305.
4. Fauci A.S., Haynes B.F., Katz P., Wolff S.M. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern M. 98:1983;76-85.
5. Hoffman G.S., Kerr G.S., Leavitt R.Y., Hallahan C.W., Lebovics R.S., Travis W.D., et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern M. 116:1992;488-498.
6. De Groot K., Reinhold-Keller E., Tatsis E., Paulsen J., Heller M., Nölle B., et al. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Arthritis Rheum. 39:1996;2052-2061.
7. Reinhold-Keller E., De Groot K., Rudert H., Nölle B., Heller M., Gross W.L. Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease. Q J M. 89:1996;15-23.
8. Reza M.J., Dornfeld M., Goldberg L.S., Bluestone R., Pearson C.M. Wegener's granulomatosis. Long term follow-up of patients treated with cyclophosphamide. Arthritis Rheum. 18:1975;501-506.
9. Pinching A.J., Rees A.J., Pussell B.A., Lockwood C.M., Mitchison R.S., Peters D.K. Relapse in Wegener's granulomatosis. Br Med J. 281:1980;836-838.
10. Andrassy K., Erb A., Koderisch J., Waldherr R., Ritz E. Wegener's granulomatosis with renal involvement: patient survival and correlation between initial renal function, renal histology, therapy and renal outcome. Clin Nephrol. 35:1991;139-147.
11. Hoffman G.S. Wegener's granulomatosis. Curr Opin Rhumatol. 5:1993;11-17.
12. Romas E., Murphy B.F., D'Aspice A.J., Kennedy J.T., Niall J.F. Wegener's granulomatosis: clinical features and prognosis in 37 patients. Aust N Z J M. 23:1993;168-175.
13. Gordon M., Luqmani R.A., Adu D., Greaves I., Richards N., Michael J., et al. Relapses in patients with systemic vasculitis. Q J M. 86:1993;779-789.
14. Van Der Werf T.S., Stegeman C.A., Meuzelaar K.J., Timens W. Late recurrence of Wegener's granulomatosis presenting as solitary upper lobe pulmonary mass. Eur Respir J. 7:1994;1365-1368.
15. Fogazzi G.B., Banfi G., Allegri L., Bignardi L. Late recurrence of systemic vasculitis after kidney transplantation involving the kydney allograft. Adv Exp Med Biol. 336:1993;503-506.
16. Piercey S., Montanaro A. Recurrent Wegener's granulomatosis: a case report and review. Ann Allergy Asthma Immunol. 76:1996;317-320.
17. Cohen-Tervaert J.W., Huitema M.G., Hene R.J., Sluiter W.J., The T.H., Van Der Hen G.K., et al. Prevention of relapses in Wegener's granulomatosis by treatment based on neutrophil cytoplasmic antibody titre. Lancet. 336:1990;709-711.
18. Girard T., Mahr A., Noël L.H., Cordier J.F., Lesavre P., Guillevin L. Antineutrophil cytoplasmic antibodies (ANCA) as a predictive factor for outcome in Wegener's granulomatosis (WG). A prospective study in 55 patients abstract Arthritis Rheum. 41:(Suppl 117):1998;505-505.
19. Boomsma M.M., Stegeman C.A., Van Der Leij M.J., Oost W., Hermans J., Kallenberg C.G., et al. Prediction of relapses in Wegener's granulomatosis by mesurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum. 43:2000;2025-2033.
20. Kerr G.S., Fleisher T.A., Hallahan C.W., Leavitt R.Y., Fauci A.S., Hoffman G.S. Limited prognostic value of change in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum. 36:1993;365-371.
21. Maguchi S., Takizawa M., Miyatake Y., Nakamuru Y., Fukuda S., Inuyama Y. Antineutrophil cytoplasmic antibody (c-ANCA) levels in relation to the treatment of Wegener's granulomatosis. Nippon Jibiinkoka Gakkai Kaiho. 98:1995;974-983.
22. Kyndt X., Reumaux D., Bridoux F., Tribout B., Bataille P., Hachulla E., et al. Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis. Am J M. 106:1999;527-533.
23. Schmitt W.H., Heesen C., Csernok E., Rautmann A., Gross W.L. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity. Arthritis Rheum. 35:1992;1088-1096.
24. Stegeman C.A., Cohen-Tervaert J.W., Huitema M.G., Kallenberg C.G.M. Serum markers of T-cell activation in relapses of Wegener's granulomatosis. Clin Exp Immunol. 91:1993;415-420.
25. Stegeman C.A., Cohen-Tervaert J.W., Sluiter W.J., Manson W.L., De Jong P.E., Kallenberg C.G.M. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis. Ann Intern M. 120:1994;12-17.
26. Guillevin L., Cordier J.F., Lhote F., Cohen P., Jarrousse B., Royer I., et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum. 40:1997;2187-2198.
27. Koldingsnes W., Gran J.T., Omdal R., Husby G. Wegener's granulomatosis: long-term follow-up of patients treated with pulse cyclophosphamide. Br J M. 37:1998;659-664.
28. Leavitt R.Y., Hoffman G.S., Fauci A.S. Response the role of trimethoprim/sulfamethoxazole in the treatment of Wegener's granulomatosis. Arthritis Rheum. 31:1988;1073-1074.
29. Stegeman C.A., Cohen-Tervaert J.W., De Jong P.E., Kallenberg C.G.M. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. abstract. N Engl J M. 335:1996;16-20.
30. Cronstein B.N. Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum. 39:1996;1951-1960.
31. Godeau B., Mainardi J.L., Roudot-Thorarval F., Hachulla E., Guillevin L., Huong Du L.T., et al. Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis. Ann Rheum Dis. 12:1995;991-994.